Pertinax Pharma Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Liquidation

Pertinax Pharma General Information

Description

Developer of antimicrobial technologies designed to be used in medical devices. The company's products can be incorporated into a wide range of medical device material substrates, including polymers and coatings, enabling healthcare professionals to offer longer antimicrobial and antifungal protection.

Contact Information

Website
www.pertinaxpharma.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Research and Enterprise Development University Of Bristol
  • 2nd Floor, Augustines Courtyard
  • Bristol BS1 5DS
  • England, United Kingdom
Primary Industry
Other Devices and Supplies
Corporate Office
  • Research and Enterprise Development University Of Bristol
  • 2nd Floor, Augustines Courtyard
  • Bristol BS1 5DS
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pertinax Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Bankruptcy: Liquidation 09-Jun-2025 Completed Bankruptcy: Liquidation
9. Early Stage VC 21-Mar-2019 Completed Generating Revenue
8. Grant 16-Jan-2019 Completed Generating Revenue
7. Early Stage VC 11-Oct-2018 Completed Generating Revenue
6. Early Stage VC 15-Mar-2017 Completed Startup
5. Grant 01-Jun-2016 Completed Startup
4. Early Stage VC 11-Apr-2016 Completed Startup
3. Grant 11-Mar-2016 Completed Startup
2. Accelerator/Incubator 01-Mar-2015 Completed Startup
1. University Spin-Out 01-Jan-2015 Completed Startup
To view Pertinax Pharma’s complete valuation and funding history, request access »

Pertinax Pharma Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
C Ordinary
A Ordinary
A Ordinary 39,000 $0.000132 $21.1 $21.1 1x $21.1 11.66%
A Ordinary 36,958 $0.000132 $15.14 $15.14 1x $15.14 11.05%
To view Pertinax Pharma’s complete cap table history, request access »

Pertinax Pharma Patents

  • 8

    Total Documents Applications and Grants

  • Total Patents Families

  • 7

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Pertinax Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2947930-A1 Antibacterial micro- and nanoparticles comprising a chlorhexidine salt, method of production and uses thereof Active 17-May-2013
CA-2947930-C Antibacterial micro- and nanoparticles comprising a chlorhexidine salt, method of production and uses thereof Active 17-May-2013
EP-2996468-A1 Antibacterial micro- and nanoparticles comprising a chlorhexidine salt, method of production and uses thereof Active 17-May-2013
EP-2996468-B1 Antibacterial micro- and nanoparticles comprising a chlorhexidine salt, method of production and uses thereof Active 17-May-2013
US-20160128332-A1 Antibacterial micro- and nanoparticles comprising a chlorhexidine salt, method of production and uses thereof Active 17-May-2013 A01N47/44
To view Pertinax Pharma’s complete patent history, request access »

Pertinax Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Pertinax Pharma FAQs

  • When was Pertinax Pharma founded?

    Pertinax Pharma was founded in 2015.

  • Where is Pertinax Pharma headquartered?

    Pertinax Pharma is headquartered in Bristol, United Kingdom.

  • What is the size of Pertinax Pharma?

    Pertinax Pharma has 4 total employees.

  • What industry is Pertinax Pharma in?

    Pertinax Pharma’s primary industry is Other Devices and Supplies.

  • Is Pertinax Pharma a private or public company?

    Pertinax Pharma is a Private company.

  • What is Pertinax Pharma’s current revenue?

    The current revenue for Pertinax Pharma is .

  • How much funding has Pertinax Pharma raised over time?

    Pertinax Pharma has raised $2.95M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process